{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:05:32Z","timestamp":1784991932901,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hebei Provincial Administration of Traditional Chinese Medicine","award":["2021167"],"award-info":[{"award-number":["2021167"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05270-6","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:10:24Z","timestamp":1784095824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between apolipoprotein A levels and chronic kidney disease stage 4\u20135 in Chinese type 2 diabetes participants"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9987-8293","authenticated-orcid":false,"given":"Feifei","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"24","key":"5270_CR1","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2013","unstructured":"Wang L, Peng W, Zhao Z et al (2013) Prevalence and treatment of diabetes in China, 2013-2018. JAMA 326(24):2498\u20132506. https:\/\/doi.org\/10.1001\/jama.2021.22208","journal-title":"JAMA"},{"issue":"4","key":"5270_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2026.5759","volume":"57","author":"M He","year":"2026","unstructured":"He M, Wang Z, Miao Z et al (2026) Post\u2011translational modifications in diabetic kidney disease (review). Int J Mol Med 57(4):1\u201326. https:\/\/doi.org\/10.3892\/ijmm.2026.5759","journal-title":"Int J Mol Med"},{"key":"5270_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/DDDT.S583077","volume":"20","author":"B Wang","year":"2026","unstructured":"Wang B, Zhang R, Liu X et al (2026) Neutrophil extracellular traps in diabetic kidney disease: mechanisms of pathogenesis and emerging therapeutic strategies. Drug Des Devel Ther 20:1\u201318. https:\/\/doi.org\/10.2147\/DDDT.S583077","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"5270_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-026-04777-5","volume":"27","author":"T Noor","year":"2026","unstructured":"Noor T, Kiran Z, Khan MT, Hanif F (2026) Predictive role and clinical correlation of copeptin in patients with type 2 diabetes mellitus associated nephropathy approaching end-stage renal disease. BMC Nephrol 27(1):145. https:\/\/doi.org\/10.1186\/s12882-026-04777-5","journal-title":"BMC Nephrol"},{"issue":"4","key":"5270_CR5","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","volume":"89","author":"ACP Souza","year":"2016","unstructured":"Souza ACP, Bocharov AV, Baranova IN et al (2016) Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int 89(4):809\u2013822. https:\/\/doi.org\/10.1016\/j.kint.2015.12.043","journal-title":"Kidney Int"},{"issue":"6","key":"5270_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1093\/ije\/dyab203","volume":"50","author":"J Zheng","year":"2022","unstructured":"Zheng J, Zhang Y, Rasheed H et al (2022) Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney disease. Int J Epidemiol 50(6):1995\u20132010. https:\/\/doi.org\/10.1093\/ije\/dyab203","journal-title":"Int J Epidemiol"},{"key":"5270_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2015.06.005","volume":"136","author":"SM Meier","year":"2015","unstructured":"Meier SM, Wultsch A, Hollaus M et al (2015) Effect of chronic kidney disease on macrophage cholesterol efflux. Life Sci 136:1\u20136. https:\/\/doi.org\/10.1016\/j.lfs.2015.06.005","journal-title":"Life Sci"},{"issue":"3","key":"5270_CR8","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/bjh.17224","volume":"193","author":"SL Saraf","year":"2021","unstructured":"Saraf SL, Zhang X, Shah BN et al (2021) Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy. Br J Haematol 193(3):628\u2013632. https:\/\/doi.org\/10.1111\/bjh.17224","journal-title":"Br J Haematol"},{"key":"5270_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.atherosclerosis.2016.06.029","volume":"251","author":"JC Bae","year":"2016","unstructured":"Bae JC, Han JM, Kwon S et al (2016) LDL-C\/apoB and HDL-C\/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort. Atherosclerosis 251:170\u2013176. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.06.029","journal-title":"Atherosclerosis"},{"issue":"3","key":"5270_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/j.ajkd.2023.03.008","volume":"82","author":"ENM de Rooij","year":"2023","unstructured":"de Rooij ENM, de Fijter JW, Le Cessie S et al (2023) Serum potassium and risk of death or kidney replacement therapy in older people with CKD stages 4\u20135: eight-year follow-up. Am J Kidney Dis 82(3):257-266.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2023.03.008","journal-title":"Am J Kidney Dis"},{"key":"5270_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111805","volume":"163","author":"J Lin","year":"2022","unstructured":"Lin J, Tang B, He G, Feng Z, Hao W, Hu W (2022) B lymphocytes subpopulations are associated with cardiac remodeling in elderly patients with advanced chronic kidney disease. Exp Gerontol 163:111805. https:\/\/doi.org\/10.1016\/j.exger.2022.111805","journal-title":"Exp Gerontol"},{"issue":"3","key":"5270_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122073","volume":"10","author":"N Neirynck","year":"2015","unstructured":"Neirynck N, Glorieux G, Schepers E, Verbeke F, Vanholder R (2015) Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study. PLoS ONE 10(3):e0122073. https:\/\/doi.org\/10.1371\/journal.pone.0122073","journal-title":"PLoS ONE"},{"issue":"5","key":"5270_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127044","volume":"10","author":"R Krishnasamy","year":"2015","unstructured":"Krishnasamy R, Isbel NM, Hawley CM et al (2015) Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS ONE 10(5):e0127044. https:\/\/doi.org\/10.1371\/journal.pone.0127044","journal-title":"PLoS ONE"},{"key":"5270_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep39372","volume":"6","author":"CC Hung","year":"2016","unstructured":"Hung CC, Lin HYH, Lee JJ et al (2016) Glycosuria and renal outcomes in patients with nondiabetic advanced chronic kidney disease. Sci Rep 6:39372. https:\/\/doi.org\/10.1038\/srep39372","journal-title":"Sci Rep"},{"issue":"2","key":"5270_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.ajkd.2009.04.029","volume":"54","author":"AS Levey","year":"2009","unstructured":"Levey AS, Cattran D, Friedman A et al (2009) Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 54(2):205\u2013226. https:\/\/doi.org\/10.1053\/j.ajkd.2009.04.029","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"5270_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677\u20131682. https:\/\/doi.org\/10.1016\/S0161-6420(03)00475-5","journal-title":"Ophthalmology"},{"issue":"5","key":"5270_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050871","volume":"11","author":"A Nurtazina","year":"2021","unstructured":"Nurtazina A, Kozhakhmetova D, Dautov D, Khaidarova N, Chattu VK (2021) Association of early renal dysfunction with lipid profile parameters among hypertensives in Kazakhstan. Diagnostics (Basel) 11(5):871. https:\/\/doi.org\/10.3390\/diagnostics11050871","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"5270_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.2215\/CJN.09830915","volume":"11","author":"Y Sato","year":"2016","unstructured":"Sato Y, Fujimoto S, Toida T et al (2016) Apoprotein B\/apoprotein A-1 ratio and mortality among prevalent dialysis patients. Clin J Am Soc Nephrol 11(5):840\u2013846. https:\/\/doi.org\/10.2215\/CJN.09830915","journal-title":"Clin J Am Soc Nephrol"},{"key":"5270_CR19","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2022.211211","author":"YD Zhou","year":"2023","unstructured":"Zhou YD, Zhu JJ, Zhang HY (2023) Correlation between apolipoprotein A1 and the occurrence and prognosis of cardiovascular events in peritoneal dialysis patients. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2022.211211","journal-title":"Clin Lab"},{"issue":"10","key":"5270_CR20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.numecd.2020.05.011","volume":"30","author":"F Moosaie","year":"2020","unstructured":"Moosaie F, Firouzabadi FD, Abouhamzeh K et al (2020) Lp(a) and apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: a case-cohort study. Nutr Metab Cardiovasc Dis 30(10):1723\u20131731. https:\/\/doi.org\/10.1016\/j.numecd.2020.05.011","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"12","key":"5270_CR21","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373\u20131379. https:\/\/doi.org\/10.1016\/S0895-4356(96)00236-3","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"5270_CR22","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S","volume":"17","author":"FY Hsieh","year":"1998","unstructured":"Hsieh FY, Bloch DA, Larsen MD (1998) A simple method of sample size calculation for linear and logistic regression. Stat Med 17(14):1623\u20131634. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19980730)17:14%3c1623::AID-SIM871%3e3.0.CO;2-S","journal-title":"Stat Med"},{"issue":"6","key":"5270_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/aje\/kwk052","volume":"165","author":"E Vittinghoff","year":"2007","unstructured":"Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 165(6):710\u2013718. https:\/\/doi.org\/10.1093\/aje\/kwk052","journal-title":"Am J Epidemiol"},{"issue":"1","key":"5270_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-016-0267-3","volume":"16","author":"M Van Smeden","year":"2016","unstructured":"Van Smeden M, De Groot JAH, Moons KGM et al (2016) No rationale for 1 variable per 10 events criterion for binary logistic regression analysis. BMC Med Res Methodol 16(1):163. https:\/\/doi.org\/10.1186\/s12874-016-0267-3","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"5270_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley RD, Snell KI, Ensor J et al (2019) Minimum sample size for developing a multivariable prediction model: PART II \u2010 binary and time\u2010to\u2010event outcomes. Stat Med 38(7):1276\u20131296. https:\/\/doi.org\/10.1002\/sim.7992","journal-title":"Stat Med"},{"issue":"4","key":"5270_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041683","volume":"26","author":"K Liu","year":"2025","unstructured":"Liu K, Cooper ME, Chai Z, Liu F (2025) High-density lipoprotein in patients with diabetic kidney disease: friend or foe? Int J Mol Sci 26(4):1683. https:\/\/doi.org\/10.3390\/ijms26041683","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5270_CR27","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.kint.2025.02.010","volume":"107","author":"A Bonnin-Marquez","year":"2025","unstructured":"Bonnin-Marquez A, Jankowski J, Maas SL et al (2025) Guanidinylation compromises the anti-inflammatory and anti-oxidative properties of apolipoprotein A-I in chronic kidney disease progression. Kidney Int 107(5):916\u2013929. https:\/\/doi.org\/10.1016\/j.kint.2025.02.010","journal-title":"Kidney Int"},{"issue":"5","key":"5270_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/joim.13437","volume":"291","author":"JP Schwaiger","year":"2022","unstructured":"Schwaiger JP, Kollerits B, Steinbrenner I et al (2022) Apolipoprotein A\u2010IV concentrations and clinical outcomes in a large chronic kidney disease cohort: results from the GCKD study. J Intern Med 291(5):622\u2013636. https:\/\/doi.org\/10.1111\/joim.13437","journal-title":"J Intern Med"},{"issue":"6","key":"5270_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011162","volume":"8","author":"KH Nam","year":"2019","unstructured":"Nam KH, Chang TI, Joo YS et al (2019) Association between serum high\u2010density lipoprotein cholesterol levels and progression of chronic kidney disease: results from the KNOW\u2010CKD. J Am Heart Assoc 8(6):e011162. https:\/\/doi.org\/10.1161\/JAHA.118.011162","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"5270_CR30","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.ekir.2025.02.007","volume":"10","author":"U Querfeld","year":"2025","unstructured":"Querfeld U, Kirchner M, Mencarelli F et al (2025) Longitudinal lipid trajectories and progression of CKD in children. Kidney Int Rep 10(5):1393\u20131403. https:\/\/doi.org\/10.1016\/j.ekir.2025.02.007","journal-title":"Kidney Int Rep"},{"issue":"13-14","key":"5270_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24954","volume":"37","author":"A Yadegar","year":"2023","unstructured":"Yadegar A, Mohammadi F, Rabizadeh S et al (2023) Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: a cross\u2010sectional survey of a regional cohort. J Clin Lab Anal 37(13\u201314):e24954. https:\/\/doi.org\/10.1002\/jcla.24954","journal-title":"J Clin Lab Anal"},{"key":"5270_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1342408","volume":"15","author":"C Yu","year":"2024","unstructured":"Yu C, Shi Y, Wang T et al (2024) Triglyceride\u2013glucose index change and chronic kidney disease progression in a Chinese hypertensive population. Front Endocrinol 15:1342408. https:\/\/doi.org\/10.3389\/fendo.2024.1342408","journal-title":"Front Endocrinol"},{"key":"5270_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2026.02.001","author":"X Wan","year":"2026","unstructured":"Wan X, Zhuang P, Lin X et al (2026) Marine n-3 fatty acids protect against renal function deterioration in diabetic patients by modulating lipoproteins and promoting cholesterol efflux. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2026.02.001","journal-title":"J Adv Res"},{"issue":"1","key":"5270_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010241","volume":"27","author":"AP Moissl-Blanke","year":"2025","unstructured":"Moissl-Blanke AP, Delgado GE, Kr\u00e4mer BK et al (2025) Serum amyloid A (SAA) and its interaction with high-density lipoprotein cholesterol (HDL-C): a comprehensive review. Int J Mol Sci 27(1):241. https:\/\/doi.org\/10.3390\/ijms27010241","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5270_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1139\/cjpp-2023-0468","volume":"102","author":"YA Rodriguez De Morales","year":"2024","unstructured":"Rodriguez De Morales YA, Abramson BL (2024) Cardiovascular and physiological risk factors in women at mid-life and beyond. Can J Physiol Pharmacol 102(8):442\u2013451. https:\/\/doi.org\/10.1139\/cjpp-2023-0468","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"5270_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-6-37","volume":"6","author":"X Yang","year":"2007","unstructured":"Yang X, Ma RC, So WY et al (2007) Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients \u2013 the Hong Kong diabetes registry. Cardiovasc Diabetol 6(1):37. https:\/\/doi.org\/10.1186\/1475-2840-6-37","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5270_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03072-1","volume":"25","author":"EWK Chow","year":"2026","unstructured":"Chow EWK, Fan Y, Wu H et al (2026) Age-specific associations between blood pressure and cardiovascular disease, kidney disease, and death among individuals with type 2 diabetes: a population-based cohort study. Cardiovasc Diabetol 25(1):60. https:\/\/doi.org\/10.1186\/s12933-025-03072-1","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"5270_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","volume":"34","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele TJ (2019) Principles of confounder selection. Eur J Epidemiol 34(3):211\u2013219. https:\/\/doi.org\/10.1007\/s10654-019-00494-6","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"5270_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jdiacomp.2013.06.002","volume":"27","author":"AJ Jenkins","year":"2013","unstructured":"Jenkins AJ, Yu J, Alaupovic P et al (2013) Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort. J Diabetes Complications 27(5):447\u2013453. https:\/\/doi.org\/10.1016\/j.jdiacomp.2013.06.002","journal-title":"J Diabetes Complications"},{"issue":"1","key":"5270_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2215\/CJN.07320619","volume":"15","author":"JA Lamprea-Montealegre","year":"2020","unstructured":"Lamprea-Montealegre JA, Staplin N, Herrington WG et al (2020) Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD. Clin J Am Soc Nephrol 15(1):47\u201360. https:\/\/doi.org\/10.2215\/CJN.07320619","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"5270_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04509-5","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang L, Zhang W et al (2023) Understanding the relationship between circulating lipids and risk of chronic kidney disease: a prospective cohort study and large-scale genetic analyses. J Transl Med 21(1):671. https:\/\/doi.org\/10.1186\/s12967-023-04509-5","journal-title":"J Transl Med"},{"issue":"1","key":"5270_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10(1):37\u201348. https:\/\/doi.org\/10.1097\/00001648-199901000-00008","journal-title":"Epidemiology"},{"key":"5270_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110118","volume":"193","author":"K Wang","year":"1995","unstructured":"Wang K, Shi M, Yang A et al (1995) GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: the Hong Kong Diabetes Register (1995\u20132019). Diabetes Res Clin Pract 193:110118. https:\/\/doi.org\/10.1016\/j.diabres.2022.110118","journal-title":"Diabetes Res Clin Pract"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05270-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05270-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05270-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:46:24Z","timestamp":1784951184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05270-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":43,"alternative-id":["5270"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05270-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this research involved a secondary analysis of publicly available de-identified data retrieved from the Dryad database, it was exempt from institutional review board (IRB) approval.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}